FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093020912> ?p ?o ?g. }

• W2093020912 abstract "Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin lymphoma (NHL) with poor prognoses; novel agents are needed for its therapy. Bruton9s tyrosine kinase (Btk) has been identified as an essential kinase for B-cell survival and it is activated through the B-cell receptor (BCR) pathway. Btk has recently emerged as a promising target in MCL, as demonstrated by recent clinical trials on the Btk inhibitor PCI-32765 (Pharmacyclics, Sunnyvale, CA), suggesting that elucidating critical signaling pathways emanating through Btk will hold an important key to deciphering the pathogenesis of MCL that can lead to the development of more effective targeted therapies. In this study, we showed that Btk is constitutively phosphorylated in most MCL cell lines except Rec1 and DB SP53 and is variable among primary cells from patients. We demonstrated that knockdown of Btk by siRNA diminished Btk expression, reduced constitutive NF-kB activation by luciferase assays, leading to the cell growth inhibition and induction of apoptosis in MCL cell lines. MCL cells treated with the Btk inhibitor PCI-32765 effectively inhibits Btk activity, leading to reduced MCL cell growth with IC 50 values range from 2-6 uM in Mino, Jeko1, Z138 and JMP1. Interestingly, the IC 50 value in DB SP53, which lacks both phosphorylated Btk and membrane immunoglobulins, is 35 uM, suggesting that BCR signaling is not active in these cell lines. PCI-32765 also induced caspase-dependent apoptosis in a dose- and time-dependent manner in representative MCL cell lines and in patient primary cells. We further demonstrated that PCI-32765 down-regulates NF-kB activity through both, the canonical and alternative NF-kB pathways. Since previous studies have indicated synergy between proteasome inhibitors and tyrosine kinase inhibitors, we evaluated whether there is synergism between PCI-32765 and the next generation proteasome inhibitor Carfilzomib (Onyx Pharmaceuticals, South San Francisco, CA). Our data suggest potential synergy between Carfilzomib and PCI-32765 in represented MCL cell lines in terms of inhibiting cell growth and induction of apoptosis. Both compounds also synergize to inhibit NF-kB activation in MCL cells. In summary, our data suggest that Btk is a key survival kinase in MCL and strategic targeting of growth/survival Btk-mediated NF-kB pathways with novel therapeutic agents such as PCI-32765 should provide a novel therapy regimen for MCL patients. Combining PCI-32765 with the proteasome inhibitor Carfilzomib can synergize its effect in MCL and may be a useful therapeutic strategy, particularly for patients with relapsed/refractory MCL. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2854. doi:1538-7445.AM2012-2854" @default.
• W2093020912 created "2016-06-24" @default.
• W2093020912 creator A5003652145 @default.
• W2093020912 creator A5006601537 @default.
• W2093020912 creator A5010204027 @default.
• W2093020912 creator A5015418500 @default.
• W2093020912 creator A5017100241 @default.
• W2093020912 creator A5017802871 @default.
• W2093020912 creator A5025740932 @default.
• W2093020912 creator A5041570474 @default.
• W2093020912 creator A5054939366 @default.
• W2093020912 creator A5058183790 @default.
• W2093020912 creator A5066599847 @default.
• W2093020912 creator A5085678821 @default.
• W2093020912 date "2012-04-15" @default.
• W2093020912 modified "2023-09-24" @default.
• W2093020912 title "Abstract 2854: Targeting constitutive NF-kB activation through Bruton's tyrosine kinase (Btk) and the proteasome in mantle cell lymphoma" @default.
• W2093020912 doi "https://doi.org/10.1158/1538-7445.am2012-2854" @default.
• W2093020912 hasPublicationYear "2012" @default.
• W2093020912 type Work @default.
• W2093020912 sameAs 2093020912 @default.
• W2093020912 citedByCount "0" @default.
• W2093020912 crossrefType "proceedings-article" @default.
• W2093020912 hasAuthorship W2093020912A5003652145 @default.
• W2093020912 hasAuthorship W2093020912A5006601537 @default.
• W2093020912 hasAuthorship W2093020912A5010204027 @default.
• W2093020912 hasAuthorship W2093020912A5015418500 @default.
• W2093020912 hasAuthorship W2093020912A5017100241 @default.
• W2093020912 hasAuthorship W2093020912A5017802871 @default.
• W2093020912 hasAuthorship W2093020912A5025740932 @default.
• W2093020912 hasAuthorship W2093020912A5041570474 @default.
• W2093020912 hasAuthorship W2093020912A5054939366 @default.
• W2093020912 hasAuthorship W2093020912A5058183790 @default.
• W2093020912 hasAuthorship W2093020912A5066599847 @default.
• W2093020912 hasAuthorship W2093020912A5085678821 @default.
• W2093020912 hasConcept C157695867 @default.
• W2093020912 hasConcept C159654299 @default.
• W2093020912 hasConcept C190283241 @default.
• W2093020912 hasConcept C203014093 @default.
• W2093020912 hasConcept C2777525834 @default.
• W2093020912 hasConcept C2777938653 @default.
• W2093020912 hasConcept C2778453870 @default.
• W2093020912 hasConcept C2778461978 @default.
• W2093020912 hasConcept C2779338263 @default.
• W2093020912 hasConcept C2779878957 @default.
• W2093020912 hasConcept C42362537 @default.
• W2093020912 hasConcept C502942594 @default.
• W2093020912 hasConcept C54355233 @default.
• W2093020912 hasConcept C55493867 @default.
• W2093020912 hasConcept C62112901 @default.
• W2093020912 hasConcept C62478195 @default.
• W2093020912 hasConcept C71924100 @default.
• W2093020912 hasConcept C81885089 @default.
• W2093020912 hasConcept C86803240 @default.
• W2093020912 hasConcept C90059517 @default.
• W2093020912 hasConcept C95444343 @default.
• W2093020912 hasConceptScore W2093020912C157695867 @default.
• W2093020912 hasConceptScore W2093020912C159654299 @default.
• W2093020912 hasConceptScore W2093020912C190283241 @default.
• W2093020912 hasConceptScore W2093020912C203014093 @default.
• W2093020912 hasConceptScore W2093020912C2777525834 @default.
• W2093020912 hasConceptScore W2093020912C2777938653 @default.
• W2093020912 hasConceptScore W2093020912C2778453870 @default.
• W2093020912 hasConceptScore W2093020912C2778461978 @default.
• W2093020912 hasConceptScore W2093020912C2779338263 @default.
• W2093020912 hasConceptScore W2093020912C2779878957 @default.
• W2093020912 hasConceptScore W2093020912C42362537 @default.
• W2093020912 hasConceptScore W2093020912C502942594 @default.
• W2093020912 hasConceptScore W2093020912C54355233 @default.
• W2093020912 hasConceptScore W2093020912C55493867 @default.
• W2093020912 hasConceptScore W2093020912C62112901 @default.
• W2093020912 hasConceptScore W2093020912C62478195 @default.
• W2093020912 hasConceptScore W2093020912C71924100 @default.
• W2093020912 hasConceptScore W2093020912C81885089 @default.
• W2093020912 hasConceptScore W2093020912C86803240 @default.
• W2093020912 hasConceptScore W2093020912C90059517 @default.
• W2093020912 hasConceptScore W2093020912C95444343 @default.
• W2093020912 hasLocation W20930209121 @default.
• W2093020912 hasOpenAccess W2093020912 @default.
• W2093020912 hasPrimaryLocation W20930209121 @default.
• W2093020912 hasRelatedWork W1999824748 @default.
• W2093020912 hasRelatedWork W2079611945 @default.
• W2093020912 hasRelatedWork W2090386979 @default.
• W2093020912 hasRelatedWork W2100293658 @default.
• W2093020912 hasRelatedWork W2270238912 @default.
• W2093020912 hasRelatedWork W2285855117 @default.
• W2093020912 hasRelatedWork W2524225259 @default.
• W2093020912 hasRelatedWork W2530938430 @default.
• W2093020912 hasRelatedWork W2551641450 @default.
• W2093020912 hasRelatedWork W2553952472 @default.
• W2093020912 hasRelatedWork W2554863425 @default.
• W2093020912 hasRelatedWork W2559317253 @default.
• W2093020912 hasRelatedWork W2588048722 @default.
• W2093020912 hasRelatedWork W2593792877 @default.
• W2093020912 hasRelatedWork W2594499083 @default.
• W2093020912 hasRelatedWork W2977107998 @default.
• W2093020912 hasRelatedWork W2980802867 @default.
• W2093020912 hasRelatedWork W3094492484 @default.
• W2093020912 hasRelatedWork W3192607872 @default.
• W2093020912 hasRelatedWork W794549589 @default.

• next